Authors: Sunderland, SJ Sarasola, P Smith, DG Hellmann, K Radeloff, I Lusky, K Doberschutz, K Laskawy, E Rowan, TG

Citation: Sj. Sunderland et al., The clinical efficacy of danofloxacin 2.5% (Advocin (R)) in the treatment of Escherichia coli infections and in vitro activity against enteric pathogens in pigs., TIER UMSCH, 56(5), 2001, pp. 235

Authors: Lusky, K Gobel, R Tesch, D Doberschutz, KD Lusky, K Haider, W

Citation: K. Lusky et al., The effects of mycotoxins OTA, ZEA and DON on the health and residue values of pigs, TIER UMSCH, 56(1), 2001, pp. 15-20

Authors: Jira, W Schwind, KH Hecht, H Lusky, K

Citation: W. Jira et al., Species-specific carry-over of toxaphene, FLEISCHWIRT, 81(11), 2001, pp. 117-119

Authors: Lusky, K Gobel, R Tesch, D Doberschutz, KD Bernau, KL Haider, W

Citation: K. Lusky et al., Sole and combined administration of the mycotoxines OTA, ZEA and DON - Investigations on animal health and residue behavior of pigs, FLEISCHWIRT, 81(10), 2001, pp. 98-102

Authors: Lusky, K Stoyke, M Grunow, M Tenner, G

Citation: K. Lusky et al., Inhibitory effect of gyrase inhibitors (gyrase inhibitor 1 and gyrase inhibitor 2) - Bacterial growth of E-coli strains in nutrient media (small tubetest) at adding of different organic matrices, FLEISCHWIRT, 80(3), 2000, pp. 96-98